Vacunación frente al virus del papiloma humano. Documento de consenso 2011 de las sociedades científicas españolas

Bordoy, Javier Cortés

doi:10.1016/j.semerg.2012.04.016

Cited by 5 publications

(4 citation statements)

References 64 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…La infección persistente por VPH de un genotipo de alto riesgo oncogénico, así como la coinfección de genotipos de alto riesgo, favorece la progresión neoplásica 3 . En los últimos años existe suficiente evidencia sobre la implicación del VPH en el origen y desarrollo del cáncer de cérvix2, 3, 4, 5. Existen dos estrategias preventivas en combinación para prevenir el cáncer de cuello uterino: la vacunación (prevención primaria) y el cribado con citología cervical (prevención secundaria).…”

Section: Introductionunclassified

“…La mayoría de países desarrollados han implantado la vacunación frente al VPH antes de la iniciación en la vida sexual4, 6. Las recomendaciones vigentes en nuestro país incluyen la vacunación sistemática de todas las mujeres entre los 9 y los 14 años y, de forma recomendable, para todas las mujeres hasta los 26 años, independientemente de su actividad sexual.…”

Section: Introductionunclassified

See 1 more Smart Citation

Conductas sexuales de riesgo y actividades preventivas frente al cáncer de cuello uterino en mujeres universitarias vacunadas frente al VPH

2018

View full text Add to dashboard Cite

show abstract

Section: Introductionunclassified

Conductas sexuales de riesgo y actividades preventivas frente al cáncer de cuello uterino en mujeres universitarias vacunadas frente al VPH

2018

View full text Add to dashboard Cite

show abstract

“…Three years later, in 2011, the impact of that document hadn´t been as successful as it was to thought it should have been. Because of persistent doubts about the usefulness of the recommendations on vaccination against HPV, its effectiveness and risk [17] a new consensus document focused on HPV vaccination was published in 2011 [18]. …”

Section: Discussionmentioning

confidence: 99%

“…No serious adverse effects related to the vaccine have been observed in none of the clinical trials done [16, 18, 21]. The most frequently reported adverse effects were transient and at the part of the body where it was injected [22].…”

Section: Discussionmentioning

confidence: 99%

Cross-sectional study about primary health care professionals views on the inclusion of the vaccine against human papillomavirus in the vaccine schedules

Oliver-Pérez

Violeta

Campo

et al. 2015

Infect Agents Cancer

View full text Add to dashboard Cite

BackgroundAlthough the inclusion of the HPV vaccine has been registered in Spain since 2007, vaccination rates are lower than expected. The patients wish to be vaccinated is heavily influenced by information they have received from many source. The Knowledge of primary health care professionals affects the information provided to patients and is fundamental in the decision making. The aim of this study is to assess the opinions of primary health care professionals on the vaccine against HPV and their knowledge about HPV infection and its links to with gynecological and oropharyngeal cancer.MethodsCross-sectional study. A 19-item survey was drawn up. It included questions on basic aspects of HPV infection and marketed vaccines, personal opinion about the inclusion in the immunization schedules and their level of prescription and recommendation to patients in their clinical practice. From October 2013 to December 2013, 607 surveys were distributed among 20 primary health centers affiliated to the University Hospital 12 de Octubre. The results were analyzed using SPSS statistical package.ResultsOne hundred sixty four successfully completed surveys were obtained for analysis. 89 % of the professionals knew about the relationship between HPV infection and cervical cancer, 57.3 % did not know any of the serotypes against which vaccines are targeted; 40.4 % believed that there is insufficient data to support the commercialization of the vaccines. Of these, 65.7 % argue that there is no data of its long-term effectiveness, 13.4 % that there is no data as to its side effects, 13.4 % believed that the cost effectiveness is not worthwhile.ConclusionsThere is a strong controversy among health professionals regarding the marketing and inclusion of HPV vaccine in immunization schedules. However, the knowledge of the primary care health professionals on key aspects of infection and vaccine protection are insufficient. The training of professionals in vaccination, cervical pathology and HPV infection should be improved to provide objective information on the use as this vaccine for patients.

show abstract

The role of flexible bronchoscopy in the upper airway pathology of immunosuppressed patients

Castellanos

Reyes

Amigo

2021

Archivos de Bronconeumología (English Edition)

View full text Add to dashboard Cite

Vacunación frente al virus del papiloma humano. Documento de consenso 2011 de las sociedades científicas españolas

Cited by 5 publications

References 64 publications

Conductas sexuales de riesgo y actividades preventivas frente al cáncer de cuello uterino en mujeres universitarias vacunadas frente al VPH

Conductas sexuales de riesgo y actividades preventivas frente al cáncer de cuello uterino en mujeres universitarias vacunadas frente al VPH

Cross-sectional study about primary health care professionals views on the inclusion of the vaccine against human papillomavirus in the vaccine schedules

The role of flexible bronchoscopy in the upper airway pathology of immunosuppressed patients

Contact Info

Product

Resources

About